Skip to content
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
  • български
Shopping Cart 16
Facebook
GPNews
  • Home
  • IssuesExpand
    • 2023
    • 2022
  • Article summariesExpand
    • AG and Neonatology
    • Allergology
    • Cardiology
    • Dental Health
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
Shopping Cart 16
Facebook

  • български

GPNews
Home / Rheumatology and Diseases of the Joints / Etoricoxib – the agent of choice in rheumatology practice

Etoricoxib – the agent of choice in rheumatology practice

отGP News публикувано на 28.08.2023 Rheumatology and Diseases of the Joints
Etoricoxib - средство на избор в ревматологичната практика

Nestorova, R., Rheumatologist
Secretary of the Bulgarian Medical Society for Osteoporosis and Osteoarthritis

NSAIDs are the most widely used drugs in rheumatology practice. Etoricoxib has become popular among the COX-2 inhibitors during the last 15 years. The safety profile of Etoricoxib is reviewed, as well as the rheumatic diseases in which it is most commonly used. The vast number of clinical studies, as well as the practical experience gathered over the years, show that Etoricoxib is the agent of choice in the treatment of rheumatic diseases, due to its proven effectiveness and good safety profile.

Key words: Etoricoxib, Effectiveness, Safety, Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Gout

Act4Diabetes
Act4Diabetes

Address for correspondence:
Nestorova, R.
Rheumatology Centre “St. Irina”
Poligona, Bl. 43
1750, Sofia

Post navigation

Previous Previous
Issue 8/2023
NextContinue
Why is the diagnosis of inflammatory rheumatological diseases delayed in out-hospital care or can we shange stereotypes?
Search
Корица 9
All issues in 2023

Issue 9/2023

Urology and nephrology Kidney stone disease: a personalized approach in minimally invasive treatment Ivanov, А. Belov, P. Antonov Congenital obstructive…

корица - 8
All issues in 2023

Issue 8/2023

Rheumatology and joint diseases Etoricoxib – the agent of choice in rheumatology practice Nestorova, R., Rheumatologist Why is the diagnosis…

корица 7
All issues in 2023

Issue 7/2023

DERMATOLGY Are autoimmune blistering diseases systemic ones? Vassileva, S., Shahid, M., Drenovska, K. Overlap syndromes in autoimmune connective tissue diseases…

fb like

About us

GPNews magazine
A peer of the GP practice in our country
The only specialized edition for general practitioners
12 monthly booklets on topics vital to your practice

Menu

  • Home
  • About us
  • Contact us

Information

  • For authors
  • Publishing ethics
  • For advertising

Copyright © 2023 GPNews. All rights reserved.

Web design and SEO by Tribest

  • GDPR
Scroll to top
  • Home
  • Issues
    • 2023
    • 2022
  • Article summaries
    • AG and Neonatology
    • Allergology
    • Cardiology
    • Dental Health
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
Search
Toзи caйт изпoлзвa „биcĸвитĸи“, зaщoтo тe ca вaжни зa нeгoвoтo фyнĸциoниpaнe. C пoceщeниeтo нa тoзи caйт, виe ce cъглacявaтe c изпoлзвaнeтo нa „биcĸвитĸитe“. - Прочети повече ...